Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, FVT

BioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024


BOTHELL, Wash., April 30, 2024 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's first quarter 2024 financial results will be released after market close on Thursday, May 9, 2024. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and give a general business update.

To access the webcast, log onto the Investor Relations page of the BioLife Solutions website at https://www.biolifesolutions.com/earnings. In addition, the conference call will be accessible by dialing toll-free 1-877-346-6112 or 1-848-280-6350 for international callers. A webcast replay will be available approximately two hours after the call and will be archived on https://investors.biolifesolutions.com for 90 days.

About BioLife Solutions
BioLife Solutions is a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X.

Media & Investor Relations

At the Company
Troy Wichterman 
Chief Financial Officer
(425) 402-1400
[email protected] 

Investors
LHA Investor Relations
Jody Cain
(310) 691-7100
[email protected]  

SOURCE BioLife Solutions, Inc.


These press releases may also interest you

at 10:31
Sequencing Kits Market to be Worth $25.29 Billion by 2031 - Exclusive Report by Meticulous Research®
According to a new market research report titled, "Sequencing Kits Market Size, Share, Forecast, & Trends Analysis  by Type (Nucleic Acid Extraction & Amplification, Library Preparation) Technology (NGS, Sanger) Application (Drug Discovery, Oncology,...

at 10:22
RICHARDS PACKAGING INCOME FUND ANNOUNCES MAY 2024 DISTRIBUTION
Richards Packaging Income Fund (the "Fund") announced today its cash distribution for the month ended May 31, 2024 of Cdn$0.11 per unit.  This distribution will be to unitholders of record at the close of business on May 31, 2024 and will be payable...

at 10:16
Canada signs $78 million bilateral agreement to help residents of Newfoundland and Labrador age with dignity
Every senior in Canada deserves to age in dignity, safety, and comfort, regardless of where they live. That is why the Government of Canada is investing close to $200 billion over 10 years, which includes $5.4 billion for tailored bilateral...

at 10:15
BRENTWOOD CAPITAL ADVISORS ELEVATES TEAM WITH THE ADDITION OF VETERAN HEALTHCARE TECHNOLOGY BANKER BRYAN CLONCS
Brentwood Capital Advisors ("BCA"), one of the nation's premier independent investment banks serving growth-oriented, middle-market Healthcare Services, Healthcare Technology, and Business Services companies, is pleased to announce that Bryan Cloncs...

at 10:13
Consumer Behavior Impacted by High Drugs, Says New Report
RazorMetrics, a healthcare technology company focused on lowering drug costs for health plans and self-funded employers, released their annual State of Drug Access report. The report is based on the findings of a consumer survey conducted through...

at 10:12
Tampa General CEO John Couris Appointed to Florida's Health Care Innovation Council
Florida Senate President Kathleen Passidomo appointed John Couris, president and CEO of Tampa General Hospital, last month to serve as a member of the Health Care Innovation Council, a statewide volunteer organization established this year to advance...

More news about Health...


News published on and distributed by: